Joshua Wallington
I joined the biotechnology team at D Young & Co in 2018 and have a strong technical background in biological sciences, with a particular focus on immunology.
Since joining the firm I have gained experience in various aspects of patent law including drafting, prosecution, oppositions and appeals. My work covers UK, European and foreign patent applications for a variety of clients, including multinational organisations, SMEs and academic institutions, and focuses on the fields of immunology, molecular biology, biotechnology and biochemistry.
Prior to joining the firm I completed my PhD in respiratory immunology at the University of Southampton, followed by subsequent post-doctoral research. My PhD and post-doctoral research investigated how T cells in the human lung respond to bacterial infection and identified a role for a newly-discovered subset of T cells in protecting the lungs from infection.
Qualifications
- BSc (Hons) in Biochemistry, University of Southampton.
- PhD in Immunology, University of Southampton.
- Certificate in Intellectual Property Law, Queen Mary, University of London, 2020.
- European Patent Attorney, 2022.
- Registered representative before the Unified Patent Court (UPC) 2023.
- Chartered Patent Attorney, 2024.
Memberships
- Chartered Institute of Patent Attorneys (CIPA).
- European Patent Institute (epi).
Publications
- Wallington J.C. et al. 2018. IL-12 and IL-7 synergize to control mucosal-associated invariant T-cell cytotoxic responses to bacterial infection. J Allergy Clin Immunol. doi: 10.1016/j.jaci.2017.08.009.
- Singhania A., Wallington J.C. et al. 2018. Multi-tissue Transcriptomics Delineates the Diversity of Airway T Cell Functions in Asthma. Am J Respir Cell Mol Biol. doi: 10.1165/rcmb.2017-0162OC.
- Hutton A.J…Wallington J.C. et al. 2017. Human Lung Fibroblasts Present Bacterial Antigens to Autologous Lung Th Cells. J Immunol. doi: 10.4049/jimmunol.1600602.